We sought to investigate the value of a family history of sudden death (SD) in Brugada syndrome (BS).
Introduction
The Brugada syndrome (BS) is characterized by coved ST elevation in the right precordial leads (V1 -3) and an increased risk of arrhythmic sudden death (SD). 1 The disease belongs to the cardiac channelopathies and is caused by mutations in genes encoding or regulating cardiac ion channels. In 20 -30% of the patients, an SCN5A gene mutation is identified. 2 In these patients, autosomal dominant inheritance has been documented. 2 In 2002 a consensus report defined the diagnostic criteria for BS. 2 A second consensus report in 2005 recommended a risk stratification scheme for the management of patients with BS. 3 In this document in asymptomatic patients without spontaneous diagnostic ECG abnormality, an electrophysiological (EP) study was advised for risk stratification in the presence of family history of sudden cardiac death suspected to be due to BS. This recommendation was based on consensus opinion given the genetic background of the disease. However, the prognostic role of a family history of SD has never been systematically investigated. The purpose of this study was to analyse in detail the characteristics and the prognostic significance of a family history of SD in BS. We sought to investigate whether a patient presenting with BS after the SD of a close relative at young age has an increased risk of future SD.
Methods

Patient population
Since 1992, all patients diagnosed with diagnostic coved type I ECG and their relatives tested for the syndrome are included both in a single and multicentre registry and are followed up in a prospective fashion. All patients included gave informed consent to participate in the registry. The Ethics Committee of the UZ Brussel-VUB has approved the study protocol. The database for the purpose of this study was assessed in December 2007.
Patients were included in the current study if they had documented spontaneous or class I antiarrhythmic drug (ADD)-induced coved type I ≥2 mm ST elevation in ≥1 lead from V1 to V3. All patients with diagnostic Brugada ECG pattern of our single-centre database were included in the study. As routine, all patients diagnosed with diagnostic type I Brugada ECG pattern were offered family screening of the firstdegree relatives. Proband was defined as the first patient of a family diagnosed with the type I Brugada ECG pattern. Familiar form of BS was defined if in addition to the proband there was at least one other family member diagnosed with type I Brugada ECG pattern. The definition of non-familiar form was used if only one member (the proband) of a family had documented diagnostic type I ECG pattern. The clinical data on these patients have been published in previous studies of our single-centre and multicentre registry.
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ECG definitions
The diagnosis of type I Brugada ECG pattern was based on the presence of coved type I ≥2 mm ST elevation in ≥1 lead from V1 to V3. Class I AAD test was performed to unmask the diagnostic ECG pattern in patients with non-diagnostic baseline ECG. Most frequently intravenous ajmaline 0.7 -1 mg/kg, administered in 5 min and less often flecainide 2 mg/kg or procainamide 10 mg/kg given over a 10-min period were used for this purpose. The test was considered positive if coved type I ECG was documented in ≥1 right precordial lead V1 -V3.
Family history of sudden death
Sudden death was defined as a natural and unexpected death that occurred within 1 h of onset of symptoms or as unwitnessed death in a previously healthy person. 10 Each patient in the database was contacted for the purpose of this study and a detailed family history was taken (questionnaire in Supplementary online material). The gender, the time of the day, and the activity at the time of the SD were specified in each victim. In each patient of the database, the relation of the suddenly deceased to the patient was classified as first-, second-, or third-degree relative. First-degree relatives were the parents, children, brothers, and sisters of an individual. Second-degree relatives were the grandparents, grandchildren, uncles and aunts, and nieces and nephews. Further relatives were classified as third degree. The age at death was categorized as ≤35 years, between 36 and 50 years and between 51 and 65 years. Sudden death events in patients .65 years of age were excluded.
Statistical analysis
Continuous variables are expressed as mean + SD or median (with inter-quartile ranges 
Family history of sudden death
In 69 (43%) of 157 families occurred SD. One hundred and ten SDs in the 69 families were analysed. Eighty-seven SD victims were male, 23 female [mean age 46 years (from 0.5 to 65 years), 42 patients (38%) were older than age 50]. Seven victims died during exercise, 26 during rest, 23 while sleeping, and 54 individuals under unknown circumstances. Thirty-one individuals died at daytime, 21 during the night, and 58 died at unknown time of the day.
One hundred and forty-nine patients (53%) had a family history of SD. Patients with family history of SD were not different from patients without a family history of SD regarding the presence of syncope or aborted SD as a presenting symptom, spontaneous type I ECG, or presence of inducibility during the EP study ( Table 2) . During follow-up Kaplan-Meier survival analysis did not show any difference in ventricular arrhythmic event (documented VF or SD)-free survival rate between patients with or without a family history of SD ( Figure 1) . Age of the SD victims was also considered as a continuous variable. Age of the SD victims did not show in the regression analysis any predictive value for ventricular arrhythmic event-free survival time.
Family history of sudden death in first-degree relatives Sixty-eight patients had a family history of SD of a first-degree relative ( Table 3) . Fifty-seven patients had one, six patients had two and five patients had three first-degree relative dying suddenly. Twenty patients had one and one patient had two first-degree relatives dying suddenly at an age ≤35 years. Patients with the family history of SD in a first-degree relative were not different from the rest of the study population regarding the presence of syncope or aborted SD as a presenting symptom, spontaneous type I ECG, or presence of inducibility during the EP study ( Table 4) . There was no significant difference in appropriate ICD shock or SD-free survival during follow-up between patients with or without a family history of SD in a first-degree relative ( Figure 2 ). Comparing patients with family history of SD in multiple firstdegree relatives to patients without family history of SD in multiple first-degree relatives, syncope or aborted SD as a presenting symptom, spontaneous type I ECG pattern, and presence of inducibility during EPS were equally frequent findings ( Table 5) . During follow-up in univariate analysis, there was no significant difference in ventricular arrhythmic event-free survival rates between patients with or without a family history of SD in multiple first-degree relatives ( Figure 3) . Similar results were observed analysing patients with a family history of SD of first-degree relatives at age ≤35 years. The occurrence of syncope or aborted SD as presenting symptom, spontaneous type I ECG pattern, or presence of inducibility during EPS did not differ significantly between patients with or without a family history of SD in a first-degree relative ≤35 years of age ( Table 6 ). Ventricular arrhythmic event-free survival was also not significantly different between these two groups of patients ( Figure 4) . However, there was one patient in the study population who had a family history of SD in two first-degree relatives at ≤35 years of age. This patient received several appropriate shocks from the ICD during follow-up. Univariate analysis showed significantly shorter event-free survival comparing this patient with a family history of two first-degree relatives dying suddenly at ≤35 years of age to the rest of the population (P , 0.001).
We repeated the comparison of ventricular arrhythmic eventfree survival rates between patients with or without a family history of single or multiple SD at any or ≤35 years of age in firstdegree relatives with stratifying patients as familiar or non-familiar form of the disease. We observed similar results; none of the highrisk subgroups of family history of SD was predictive in univariate analysis of shorter survival.
Family history of sudden death in second-degree relatives Eighty-one patients had a family history of SD in a second-degree family member ( Table 3) . Fifty-six patients had 1, 21 patients had 2 and 4 patients had 3 second-degree family member dying suddenly. Patients with the family history of SD in a second-degree relative were not different from the rest of the study population regarding the presence of syncope or aborted SD as a presenting symptom, spontaneous type I ECG, or presence of inducibility during the EP study. Comparing patients with or without a family history of SD in a second-degree relative Kaplan-Meier survival analysis did not show any significant difference in event-free survival rates. Similar results were observed combining the subgroup of patients with a family history of SD in first-and/or second-degree relatives. Additionally, event-free survival time did not differ between patients with or without a family history of multiple SDs at any age in first-and/or second-degree relatives. Similarly, the family history of SD in a single first-or second-degree family member at age ≤35 years was not predictive of shorter event-free survival during follow-up.
Risk factors for arrhythmic events during follow-up
In univariate analysis family history of multiple SDs in first-degree relative ≤35 years (P , 0.001), male gender (P ¼ 0. Values represent the percentage of the total study population of 280 patients.
A. Sarkozy et al.
SD (P , 0.001), syncope (P ¼ 0.04), the presence of spontaneous type I ECG (P , 0.001), and inducibility during EP study (P , 0.001) were associated with significantly shorter documented VF or SD-free survival. We also compared patients who had no family history of SD or syncope nor aborted SD to patients who had at least one of these risk factors. Patients without any of these risk factors had similar event rates as patients with one of these risk factors (3 of 93 patients vs. 15 of 184 patients, P ¼ 0.13). In contrast, the absence of syncope, aborted SD, spontaneous type I ECG, and inducibility during EP study was associated with significantly better prognosis (P , 0.001). Only one of the 167 patients without any of these risk factors died suddenly during follow-up. In contrast, 17 of the 109 patients with at least one of these risk factors had received appropriate ICD shock or died suddenly during follow-up.
Discussion
In the current study, we evaluated the role of the family history of SD in BS. In several previous multicentre registries the predictive value of the family history of SD in general was analysed. Brugada et al. 5, 6 reported in both symptomatic and asymptomatic patients that the family history of SD was not predictive neither in univariate nor in multivariate analysis of future arrhythmic events. In an Italian multicentre registry family history of SD was not predictive of lethal arrhythmic events. 11, 12 In these studies age cut-off was not used for the definition of SD and the degree of relation to the index patient was not evaluated. In the most recently reported FINGER multicentre registry, 1029 patients were included. 13 In this study, the role of the family history of SD under age 45 years was investigated. Twenty-six per cent of the patients had a family history of SD under this age. In this study population, the family history of SD was not predictive of arrhythmic events. In contrast to the above-mentioned European studies, in a recent, smaller Japanese study including 330 probands, a family history of SD ≤45 years of age was a predictor of poor survival in multivariate analysis. 14 However, in all these studies the degree of relation, the age of the SD victim, and the role of multiple SDs in one family were not evaluated.
In the current study, we evaluated for the first time in detail the role of a family history of SD in BS. The aim of our study was to identify a subgroup of patients with high-risk features of family Table 5 Baseline clinical characteristics of patients with family history of sudden death of multiple first-degree relatives compared to patients without family history of sudden death of multiple first-degree relatives without a family history of sudden death in multiple first-degree relatives at any age. SD, sudden death.
Family history of SD in BS history of SD, in which the family history might be predictive for future arrhythmic events in the index patients. First, we examined the importance of age at the time of SD. We used the predefined age categories of ≤35 years; between 36 and 50; and between 51 to 65 years of age. We considered 65 years of age as upper cut-off. We decided to use these preclassified categories based on epidemiological data of SD. It was previously reported, that in the adult population the incidence of SD is high and the most common cause by far is coronary artery disease, accounting for 80% of all sudden cardiac deaths. 15 In contrast, in the children-adolescent population SD is rare; its incidence is 1/100th of those of the adult population, and it has a distinctly different aetiology. 15, 16 Between age 1 and 35, the most frequently identified organic heart diseases at autopsy of sudden cardiac death victims are hypertrophic cardiomyopathy, myocarditis, coronary artery disease, congenital coronary artery anomalies, and congenital heart lesions. 15, 16 However, it is estimated that from 30 up to 70% of SDs occur in previously healthy infants, children, adolescents, and young adults with no abnormal findings at autopsy. 16 -18 Recently, post-mortem molecular analysis provided strong evidence that a significant number of these unexplained SDs are caused by channelopathies. 19, 20 Based on these findings, we hypothesized that SDs under 35 years of age in families with BS are most likely to be due to BS. We expected that these families might have the most severe manifestation of the disease, thus SD at this very young age might have a higher prognostic value.
The second category of age we used was between 36 and 50 years. We took into consideration that patients having the most severe form of BS die suddenly in their early forties. However, based on epidemiological data, in this age category SD due to coronary artery disease also starts to play a role. 15 Finally, we chose the third-age category between 50 and 65 years of age. Given the epidemiological data on the age distribution of SD, in this age category even with families with BS coronary artery disease is more likely to be the aetiology for SD, thus we expected the least prognostic significance in this category. Using these three predefined categories of age, we could also take into account the difference between one vs. multiple SD victims in each category. Multiple SDs in one family caused by high-risk mutation described in other genetic cardiac diseases were also expected to predict a higher risk for the index patient. 21 Finally, given the autosomal dominant inheritance of the SCN5A gene mutation reported in the familial form of the disease we hypothesized that the relation of the patient to the SD victim might also be important. We expected first-degree relatives of the SD victims to be at higher risk than second-or third-degree relatives. The current study is the first report in a genetic disease to analyse the value of a family history of SD considering the age, relation, and number of SD victims in the family. In the current study, 50% of our study population had a family history of SD at ≤65 years of age. However, close to 40% of these SDs occurred in individuals older than 50 years of age. The large majority of victims were men. Furthermore, and in spite of a detailed questionnaire, patients were unable to describe the exact circumstances of death in .50% of the cases. In the remaining cases, the large majority of victims died in rest or up to 40% during sleeping.
Our findings show that a family history of SD is not predictive for future arrhythmic events in an index patient. The lack of predictive value was observed even if considering only SDs in first-degree relatives, multiple SDs in first-or second-degree relatives or SDs in first-or second-degree relatives at a very young age (≤35 years). Given the medium-term follow-up and the relatively low event rates, to confirm this finding we compared the incidence of highrisk baseline clinical characteristics in patients with high-risk features of family history of SD to the rest of the population. Aborted SD or syncope as presenting symptom, spontaneous type I ECG, or inducibility during an EP study were not more frequent among patients with a family history of SD. The only exception in our study was the presence of a family history of multiple SDs in first-degree relatives at age ≤35 years. However, this finding was very infrequent and occurred only in one patient in our study population. This is likely due to the high mortality of these families. The clinical significance of this finding needs further evaluation. The lack of prognostic value of a family history of SD has several potential explanations. First, only in a minority of cases were autopsy data available. Especially in the population .50 years of age coronary artery disease or other causes of SD might be present. Second, variable clinical expression of BS even in members of the same family carrying the same mutation has been described. 2 This observation might be due to the fact that the clinical manifestation of the disease is also influenced by environmental factors (viral infections, ADDs, hormonal influence). This might explain the little role of a family history of SD. Alternatively, it is well known that the road from a monogenic mutation to cardiac ion channel dysfunction is very long. It is possible that singlenucleotide polymorphisms, rare or frequent variants in other genes, thus the individual genetic background of each patient may play the most important role in the clinical expression of a disease. Our findings have important clinical implications. In clinical practice patients are frequently being diagnosed with BS during the family screening following SD(s) of a close relative at a young age. In these patients the diagnosis of the same disease in the index patient as in the SD victim has frequently important psychological consequences. Based on our results, we can reassure these patients that unless they have multiple first-degree relatives who died suddenly ≤35 years of age, the SD in their family on medium term does not indicate a higher risk.
Limitations
In the majority of cases autopsy has not been performed thus other causes of SD were not excluded. The age cut-off of 65 years and the categories were arbitrary defined. The event rate in our study was low during follow-up and the mean follow-up was only 5 years. Furthermore children were not excluded. In a disease with life-long risk of lethal arrhythmias enough to occur once in a lifetime this study has not enough power to definitely exclude or confirm the predictive value of any parameter. For this reason, multivariable analysis was not performed.
Conclusions
The current study is the first report in a genetic disease to analyse the value of a family history of SD considering age, relation, and number of SD victims. We report the important finding that a family history of SD is not predictive for future arrhythmic events even if considering only SDs in first-degree relatives or SD in first-and second-degree relatives at a very young age (,35 years). The only exception in our study was the presence of the family history of multiple SDs in first-degree relatives under age 35 years. However, this finding was very infrequent and further studies should confirm its clinical significance. In the meantime the recommendation of the second consensus report should be revised. For risk stratification purposes in asymptomatic individuals without spontaneous type I ECG, the decision to perform an EP study should not be based on the family history of SD.
Another important finding of our study is that the absence of syncope, aborted SD, spontaneous type I ECG, and inducibility during EP study was associated with a good five-year prognosis.
